Metropolitan Life Insurance CO Werewolf Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$3.71 - $12.22 $31,386 - $103,381
-8,460 Closed
0 $0
Q4 2021

Jun 21, 2023
BUY
$11.48 - $17.65 $97,120 - $149,319
8,460 New
8,460 $100,000
Q4 2021

Mar 30, 2023
BUY
$11.48 - $17.65 $97,120 - $149,319
8,460 New
8,460 $100,000
Q4 2021

Feb 15, 2022
BUY
$11.48 - $17.65 $97,120 - $149,319
8,460 New
8,460 $101,000

Others Institutions Holding HOWL

# of Institutions
69
Shares Held
31.8M
Call Options Held
700
Put Options Held
500
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $46.4M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email